Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516407 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Electronic (PDF)Add to Basket
Hard CopyAdd to Basket
Electronic (Online Access)Add to Basket
EnterprisewideAdd to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

Generic Drugs: Global collaboration opportunities

Espicom Business Intelligence Ltd, Dec 2011, Pages: 410


  Description  
   Companies Mentioned   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Key Facts, Statistics and Insights on 160 Medium-sized Generic Manufacturers Based in 35 Countries!

Collaboration is the key to growth:

In the current economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.

At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of branded medicines have made moves to increase generic prescribing.

But pressure on health spending is seeing downward pressure on generic prices. With lower margins this is creating pain for generics companies.

SME Generic companies offer focused opportunities:

With established markets compromised, where can the industry go? Expansion in the sector has been seen through more partnering, either through outright acquisition to increase market share or through product and marketing licensing. Being bigger and having improved market access is seen as a way of distributing cost and strengthening revenues. While major players such as Teva and Sandoz play an international role, there are a number of established and progressive generic manufacturers worthy of consideration.

Delivering the key content you need:

This new report from Espicom is a key resource for the wide assessment of 160 medium-sized generic companies operating in 35 markets worldwide. The report provides an essential and comprehensive evaluation of each company, including:

- Background
- A summary of the company's foundation and main business interests
- Product range
- Details of ANDAs approved or products/therapy areas represented
- Financial
- Financial performance or funding data
- Strategic alliances
- Details of significant marketing and supply agreements
- Contact information
- Postal, telephone, fax and website details

REASONS TO BUY

Use this report to…

- Identify commercial partners to secure new markets, technologies and revenues
- Assess merger and acquisition targets
- Understand the developing generic industry in key markets worldwide
- Profile the competitive environment in the increasingly important medium-sized company sector
- Seek out companies manufacturing/marketing similar product lines
- Assess the investment potential of these developing companies


Product samples

A sample for this product is available. Please Login/Register to download this sample.

For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds